Physician profile
Barry O Conlan
NPI 1568462158
$4,294.87
in general payments reported to CMS, 2019-2025
38 companies · $811 in 2025
The $811 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.80 · 2021: $633 · 2022: $1,053 · 2023: $724 · 2024: $1,062 · 2025: $811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,597.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $750.76 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $618.90 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $373.33 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $367.73 | 2021-2025 | |
| Glaxosmithkline, LLC. | $223.85 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $221.99 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.90 | 2021-2025 | Xifaxan |
| Welch Allyn | $117.71 | 2021 | |
| Baxter Healthcare | $117.71 | 2022 | |
| Astellas Pharma US INC | $113.86 | 2021-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.61 | 2020-2022 | |
| Exact Sciences Corporation | $102.49 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $90.23 | 2021-2025 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $88.31 | 2023-2024 | Auvelity, Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $86.50 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Conlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.